Vytorin has been shown to reduce potentially heart problems in patients with chronic kidney disease (CKD) in a new study. …
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board

